Format

Send to

Choose Destination
Clin Infect Dis. 2010 Jul 1;51(1):79-84. doi: 10.1086/653120.

Treatment of Acinetobacter infections.

Author information

1
Division of Infectious Diseases, St John Hospital and Medical Center, Detroit, Michigan 48236, USA. Joel.Fishbain@stjohn.org

Abstract

Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.

PMID:
20504234
DOI:
10.1086/653120
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center